Literature DB >> 19960506

A rapid ultra-performance liquid chromatography/tandem mass spectrometric methodology for the in vitro analysis of Pooled and Cocktail cytochrome P450 assays.

Peter G Alden1, Robert S Plumb, Michael D Jones, Paul D Rainville, Darcy Shave.   

Abstract

Drug-drug interaction evaluations of new pharmaceutical candidates are critical to preventing drug withdrawal and are routinely determined through the use of cytochrome P450 assays. The measurement of the effect of test compounds on the metabolism of known substrates allows for the determination of specific CYP450 isoenzyme inhibition and calculation of IC50 values. A sensitive, high-throughput ultra-performance liquid chromatography/tandem mass spectrometric (UPLC/MS/MS) method is presented for the evaluation of CYP450 inhibition. The assay was performed using a cocktail of probe substrates and the results were compared to those obtained with the more time-consuming methodology utilizing individual substrates. The use of a high-resolution, sub-2 microm particle, LC system allowed for a high-throughput assay of just 1 min. The extra resolution of the UPLC/MS/MS system allowed for the complete resolution of the analytes, with a fast switching MS for comprehensive data collection. The CYP450 inhibition results obtained using the substrate cocktail approach were found to be essentially identical to those obtained using individual substrates. Copyright 2009 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2010        PMID: 19960506     DOI: 10.1002/rcm.4364

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  7 in total

1.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

2.  High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions.

Authors:  Guannan Li; Ke Huang; Dejan Nikolic; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2015-08-18       Impact factor: 3.922

3.  Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19.

Authors:  Sandhya Devarajan; Irene Moon; Ming-Fen Ho; Nicholas B Larson; Drew R Neavin; Ann M Moyer; John L Black; Suzette J Bielinski; Steven E Scherer; Liewei Wang; Richard M Weinshilboum; Joel M Reid
Journal:  Drug Metab Dispos       Date:  2019-02-11       Impact factor: 3.922

4.  Effect of Repeated Wuniu Early Tea Administration on the CYP450 Activity Using a Cocktail Method.

Authors:  R A Xu; Z S Xu; G Y Lin; L F Hu; X Q Wang; J S Ma
Journal:  Indian J Pharm Sci       Date:  2013-01       Impact factor: 0.975

5.  An in-vitro cocktail assay for assessing compound-mediated inhibition of six major cytochrome P450 enzymes.

Authors:  Jing-Jing Wang; Jian-Jun Guo; Jenny Zhan; Hai-Zhi Bu; Jiunn H Lin
Journal:  J Pharm Anal       Date:  2014-02-14

6.  Simultaneous determination of cytochrome P450 1A, 2A and 3A activities in porcine liver microsomes.

Authors:  Monika Johansson; Jana Tomankova; Shengjie Li; Galia Zamaratskaia
Journal:  Interdiscip Toxicol       Date:  2012-09

7.  Dataset from proteomic analysis of human liver, lung, kidney and intestine microsomes.

Authors:  Wei Song; Longjiang Yu; Zhihong Peng
Journal:  Data Brief       Date:  2018-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.